A guide to the composition and functions of the extracellular matrix NK Karamanos, AD Theocharis, Z Piperigkou, D Manou, A Passi, ... The FEBS journal 288 (24), 6850-6912, 2021 | 548 | 2021 |
Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells V Masola, G Gambaro, E Tibaldi, AM Brunati, A Gastaldello, A D'Angelo, ... Journal of Biological Chemistry 287 (2), 1478-1488, 2012 | 126 | 2012 |
Heparanase: A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events V Masola, G Bellin, G Gambaro, M Onisto Cells 7 (12), 236, 2018 | 102 | 2018 |
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. V Masola, G Zaza, M Onisto, A Lupo, G Gambaro International angiology: a journal of the International Union of Angiology …, 2014 | 99 | 2014 |
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients S Granata, V Masola, E Zoratti, MT Scupoli, A Baruzzi, M Messa, ... PloS one 10 (3), e0122272, 2015 | 94 | 2015 |
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition V Masola, M Onisto, G Zaza, A Lupo, G Gambaro Journal of translational medicine 10 (1), 1-7, 2012 | 94 | 2012 |
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity V Masola, G Zaza, MF Secchi, G Gambaro, A Lupo, M Onisto Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1843 (9), 2122-2128, 2014 | 79 | 2014 |
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients G Zaza, S Granata, V Masola, C Rugiu, F Fantin, L Gesualdo, FP Schena, ... PloS one 8 (10), e77847, 2013 | 78 | 2013 |
Role of heparanase in tumor progression: Molecular aspects and therapeutic options V Masola, G Zaza, G Gambaro, M Franchi, M Onisto Seminars in Cancer Biology 62, 86-98, 2020 | 76 | 2020 |
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells V Masola, A Carraro, S Granata, L Signorini, G Bellin, P Violi, A Lupo, ... Journal of translational medicine 17 (1), 1-11, 2019 | 73 | 2019 |
Impact of heparanase on renal fibrosis V Masola, G Zaza, M Onisto, A Lupo, G Gambaro Journal of translational medicine 13, 1-7, 2015 | 59 | 2015 |
Heparanase: a potential new factor involved in the renal epithelial mesenchymal transition (EMT) induced by ischemia/reperfusion (I/R) injury V Masola, G Zaza, G Gambaro, M Onisto, G Bellin, G Vischini, I Khamaysi, ... PloS one 11 (7), e0160074, 2016 | 56 | 2016 |
Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells V Masola, G Gambaro, E Tibaldi, M Onisto, C Abaterusso, A Lupo Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1813 (8), 1475-1482, 2011 | 53 | 2011 |
Extracellular Matrix-Mediated Breast Cancer Cells Morphological Alterations, Invasiveness, and Microvesicles/Exosomes Release M Franchi, Z Piperigkou, KA Karamanos, L Franchi, V Masola Cells 9 (9), 2031, 2020 | 50 | 2020 |
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury V Masola, G Zaza, G Bellin, L Dall'Olmo, S Granata, G Vischini, ... The FASEB Journal 32 (2), 742-756, 2018 | 50 | 2018 |
Recent data concerning heparanase: focus on fibrosis, inflammation and cancer MF Secchi, V Masola, G Zaza, A Lupo, G Gambaro, M Onisto Biomolecular concepts 6 (5-6), 415-421, 2015 | 48 | 2015 |
Molecular size-dependent specificity of hyaluronan on functional properties, morphology and matrix composition of mammary cancer cells AG Tavianatou, Z Piperigkou, C Barbera, R Beninatto, V Masola, I Caon, ... Matrix Biology Plus 3, 100008, 2019 | 44 | 2019 |
Heparanase and macrophage interplay in the onset of liver fibrosis MF Secchi, M Crescenzi, V Masola, FP Russo, A Floreani, M Onisto Scientific Reports 7 (1), 14956, 2017 | 43 | 2017 |
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545 Z Abassi, S Hamoud, A Hassan, I Khamaysi, O Nativ, SN Heyman, ... Oncotarget 8 (21), 34191, 2017 | 41 | 2017 |
Heparanase as a Target in Cancer Therapy V Masola, M Francesca Secchi, G Gambaro, M Onisto Current cancer drug targets 14 (3), 286-293, 2014 | 39 | 2014 |